A man with a grocery cart full of produce looks at his phone in a grocery store
Employee Benefits

How GLP-1 Medications Are Reshaping Consumer Behavior

From declining alcohol sales to shifts in grocery spending and vacation preferences, GLP-1 medications are influencing consumer behavior in ways that employers and benefit consultants can’t afford to ignore.
Marc Pinney
Marc Pinney
Vice President, Employee Benefits

What started as a medical breakthrough for weight loss is now a full-blown cultural shift. GLP-1 medications like Ozempic, Wegovy, and Zepbound aren’t just helping people shed pounds, they’re subtly reshaping how we eat, drink, and even vacation.

From declining liquor sales to changing grocery carts and travel choices, these medications are influencing behaviors in unexpected ways. And for employers and benefit consultants, the ripple effects are too big to ignore when evaluating your Employee Benefits strategies.

Slipping Liquor Sales

One of the most surprising side effects of GLP-1 drugs is the impact on alcohol consumption. These medications influence the brain’s reward pathways, reducing cravings not just for food but also for substances like alcohol.

A recent study by Cornell University and Numerator found that households with GLP-1 users reduced alcohol purchases by 1.4%, with heavier drinkers showing even more pronounced declines. That may sound small, but in an industry where growth is measured in tenths of a percent, it’s enough to make a difference.

This shift is already being felt in the liquor industry. Bars and beverage companies are seeing subtle but measurable changes in consumer behavior, prompting some to pivot toward low-alcohol or wellness-oriented offerings. For employers, this could mean fewer alcohol-related health claims and a shift in workplace culture around social events.

Decreased Grocery Spending

GLP-1 users are buying less food overall, particularly in categories like processed snacks, sugary drinks, and baked goods. Grocery spending dropped by 6% in the six months following GLP-1 adoption, with snack purchases down by 11%. This isn’t just about eating less; it’s about eating differently. Users are gravitating toward nutrient-dense foods, fresh produce, and smaller portions.

Eye Health Concerns

Emerging research suggests a possible link between GLP-1 use and neovascular age-related macular degeneration (AMD), a leading cause of blindness. While the data is still early, it’s a reminder that even miracle drugs come with caveats. Employers may want to consider adding routine eye exams to wellness offerings or highlighting this risk in educational materials.

Potential Mental Health and Addiction Treatment

GLP-1 medications may also hold promise for treating addictive behaviors beyond alcohol. Early studies suggest they could help reduce cravings for nicotine, compulsive eating, and even gambling. This opens up new avenues for behavioral health coverage and integrated care models.

Evolving Travel Preferences

GLP-1 users are increasingly choosing active vacations over indulgent getaways. Wellness resorts, hiking trips, and curated healthy experiences are gaining popularity. Hospitality brands are adapting by offering nutritious meal options, fitness amenities, and wellness packages.

This shift could influence corporate travel policies and employee perks, especially for companies looking to align benefits with evolving health trends.

Medical Imaging Challenges

A lesser-known but clinically significant side effect of GLP-1 drugs is their impact on PET-CT scans. These medications can alter the uptake of radioactive tracers, potentially leading to misinterpretation of cancer imaging. Radiologists have reported “hot spots” that mimic tumors or inflammation, which can complicate diagnoses and treatment plans.  

Takeaways for Employers and Benefit Consultants

As GLP-1 medications continue to reshape consumer behavior, benefit consultants have a unique opportunity to lead the conversation:

  • Reevaluate coverage for GLP-1 medications, especially as their benefits extend beyond weight loss.
  • Integrate behavioral health and lifestyle support into wellness programs.
  • Educate employees on the broader impacts of these medications, including potential side effects and lifestyle changes.
  • Partner with vendors offering digital health platforms, nutrition coaching, and fitness support tailored to GLP-1 users.

GLP-1 drugs are more than a medical breakthrough—they’re a cultural and economic disruptor. Understanding their impact can help employers stay ahead of the curve and design benefit strategies that reflect the evolving needs of the workforce. Our Employee Benefits consultants are constantly monitoring trends and providing key insights to empower HR and benefits leaders to make the right choice for their teams. When you’re ready to take your strategy to the next level, reach out to learn more about our services.

Explore more from Holmes Murphy